Ezetimibe: an update on its clinical usefulness in specific patient groups

被引：47

作者：

Hammersley, Daniel ^{[2
]}

Signy, Mark ^{[1
]}

机构：

[1] Worthing Dist Hosp, Dept Cardiol, Lyndhurst Rd, Worthing BN11 2DH, W Sussex, England

[2] Western Sussex Hosp NHS Trust, Dept Cardiol, Worthing, W Sussex, England

来源：

THERAPEUTIC ADVANCES IN CHRONIC DISEASE | 2017年 / 8卷 / 01期

关键词：

cholesterol; dyslipidaemias; ezetimibe; hypercholesterolaemias; hyperlipidaemia; lipids; low-density lipoprotein; INTESTINAL CHOLESTEROL ABSORPTION; SIMVASTATIN; STATIN; DISEASE; ATORVASTATIN; THERAPY; PLUS; MONOTHERAPY; PREVENTION; EFFICACY;

D O I：

10.1177/2040622316672544

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The aim of pharmacological lipid modification is to reduce low-density lipoprotein cholesterol (LDL-C) as a means of either secondary or primary prevention of cardiovascular disease. Statins are the first-line therapy for pharmacological lipid modification. Ezetimibe is a drug which reduces LDL-C by selectively inhibiting intestinal cholesterol absorption. This provides an alternative pharmacological approach to that of statin therapy to reduce LDL-C. Ezetimibe has been shown to significantly reduce levels of LDL-C and recently, as demonstrated in the IMPROVE-IT trial, to reduce the rate of cardiovascular events in high-risk patients. Ezetimibe therefore has an important role in pharmacological lipid modification. In this paper, we examine the body of research behind ezetimibe and assess its current clinical applications in different patient subgroups.

引用

页码：4 / 11

页数：8

共 37 条

[1]

[Anonymous], 2014, 10 LEAD CAUS DEATH W

[2]

[Anonymous], 2015, FDA BRIEF DOC

[3] Cholesterol Metabolism and Statin Effectiveness in Hemodialysis Patients [J].

Baigent, Colin .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (21) :2299-2301

[4] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].

Baigent, Colin ;

Landray, Martin J. ;

Reith, Christina ;

Emberson, Jonathan ;

Wheeler, David C. ;

Tomson, Charles ;

Wanner, Christoph ;

Krane, Vera ;

Cass, Alan ;

Craig, Jonathan ;

Neal, Bruce ;

Jiang, Lixin ;

Hooi, Lai Seong ;

Levin, Adeera ;

Agodoa, Lawrence ;

Gaziano, Mike ;

Kasiske, Bertram ;

Walker, Robert ;

Massy, Ziad A. ;

Feldt-Rasmussen, Bo ;

Krairittichai, Udom ;

Ophascharoensuk, Vuddidhej ;

Fellstrom, Bengt ;

Holdaas, Hallvard ;

Tesar, Vladimir ;

Wiecek, Andrzej ;

Grobbee, Diederick ;

de Zeeuw, Dick ;

Gronhagen-Riska, Carola ;

Dasgupta, Tanaji ;

Lewis, David ;

Herrington, William ;

Mafham, Marion ;

Majoni, William ;

Wallendszus, Karl ;

Grimm, Richard ;

Pedersen, Terje ;

Tobert, Jonathan ;

Armitage, Jane ;

Baxter, Alex ;

Bray, Christopher ;

Chen, Yiping ;

Chen, Zhengming ;

Hill, Michael ;

Knott, Carol ;

Parish, Sarah ;

Simpson, David ;

Sleight, Peter ;

Young, Alan ;

Collins, Rory .

LANCET, 2011, 377 (9784) :2181-2192

[5] Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial [J].

Ballantyne, CM ;

Houri, J ;

Notarbartolo, A ;

Melani, L ;

Lipka, LJ ;

Suresh, R ;

Sun, S ;

LeBeaut, AP ;

Sager, PT ;

Veltri, EP .

CIRCULATION, 2003, 107 (19) :2409-2415

[6] IMPROVE-IT: what have we learned? [J].

Banach, Maciej ;

Nikolic, Dragana ;

Rizzo, Manfredi ;

Toth, Peter P. .

CURRENT OPINION IN CARDIOLOGY, 2016, 31 (04) :426-433

[7] Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel [J].

Banach, Maciej ;

Rizzo, Manfredi ;

Toth, Peter P. ;

Farnier, Michel ;

Davidson, Michael H. ;

Al-Rasadi, Khalid ;

Aronow, Wilbert S. ;

Athyros, Vasilis ;

Djuric, Dragan M. ;

Ezhov, Marat V. ;

Greenfield, Robert S. ;

Hovingh, G. Kees ;

Kostner, Karam ;

Serban, Corina ;

Lighezan, Daniel ;

Fras, Zlatko ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Goudev, Assen ;

Ceska, Richard ;

Nicholls, Stephen J. ;

Broncel, Marlena ;

Nikolic, Dragana ;

Pella, Daniel ;

Puri, Raman ;

Rysz, Jacek ;

Wong, Nathan D. ;

Bajnok, Laszlo ;

Jones, Steven R. ;

Ray, Kausik K. ;

Mikhailidis, Dimitri P. .

ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) :1-23

[8] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].

Cannon, Christopher P. ;

Blazing, Michael A. ;

Giugliano, Robert P. ;

McCagg, Amy ;

White, Jennifer A. ;

Theroux, Pierre ;

Darius, Harald ;

Lewis, Basil S. ;

Ophuis, Ton Oude ;

Jukema, J. Wouter ;

De Ferrari, Gaetano M. ;

Ruzyllo, Witold ;

De Lucca, Paul ;

Im, KyungAh ;

Bohula, Erin A. ;

Reist, Craig ;

Wiviott, Stephen D. ;

Tershakovec, Andrew M. ;

Musliner, Thomas A. ;

Braunwald, Eugene ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397

[9] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[10] ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J].

Catapano, Alberico L. ;

Reiner, Zeljko ;

De Backer, Guy ;

Graham, Ian ;

Taskinen, Marja-Riitta ;

Wiklund, Olov ;

Agewall, Stefan ;

Alegria, Eduardo ;

Chapman, M. John ;

Durrington, Paul ;

Erdine, Serap ;

Halcox, Julian ;

Hobbs, Richard ;

Kjekshus, John ;

Filardi, Pasquale Perrone ;

Riccardi, Gabriele ;

Storey, Robert F. ;

Wood, David .

ATHEROSCLEROSIS, 2011, 217 (01) :3-46

← 1 2 3 4 →